Proteogenomics identifies c-Met inhibition as a therapeutic strategy for BAP1-deficient clear cell renal cell carcinoma

Affiliations

• ¹ Department of Urology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. dubwac@gmail.com.
• ² Department of Urology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
• ³ Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
• ⁴ Department of Urology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. hohowell@163.com.
• ⁵ Department of Urology, Affiliated Zhongda Hospital of Southeast University, Nanjing, China. mingchen0712@seu.edu.cn.
• ⁶ Department of Urology, Jiangnan University Medical Center, Wuxi, China. n.feng@njmu.edu.cn.